Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)
Recruiting
1,000 enrolled
Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy
Recruiting
60 enrolled
Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant
Recruiting
88 enrolled
Clinical, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Hematologic Cancer
Active not recruiting
1,836 enrolled
Leukapheresis for CAR or Adoptive Cell Therapy Manufacturing
Enrolling by invitation
120 enrolled
Genome Expression in Lymphoma, Leukemia and Multiple Myeloma
Completed
1,340 enrolled
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Recruiting
30 enrolled
Frequency of Cachexia in Ambulatory Cancer Patients and Psychological Burden in Patients and Their Primary Caregivers
Active not recruiting
192 enrolled
NICHE
Recruiting
2,300 enrolled
CVE-CART
Completed
44 enrolled
Improving Communication and Building a Stronger Medical Home Among Spanish-speaking Families
Recruiting
20 enrolled
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
Recruiting
500 enrolled
Pre-malignant States to Hematologic Malignancies in Firefighters
Recruiting
300 enrolled
CAMPERR
Recruiting
7,000 enrolled
Bone Marrow Grafting for Leukemia and Lymphoma
Enrolling by invitation
9,999 enrolled
QOL-ONE PRO-CT
Not yet recruiting
162 enrolled
VeRVe
Recruiting
500 enrolled
EPOCH
Recruiting
45 enrolled
HTLV-OBS
Recruiting
120 enrolled
Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies
Recruiting
100 enrolled
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Recruiting
15,000 enrolled
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
Recruiting
40 enrolled
REBOUND
Completed
126 enrolled
YASU Research Registry: For Young Adults With Cancer
Terminated
192 enrolled
HALO-SCT
Recruiting
1,000 enrolled
A Treatment Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
Recruiting
500 enrolled
Wearable Sensors and Molecular Omics to Detect and Mitigate Cell Therapy Adverse Events
Completed
11 enrolled
succinylation
Not yet recruiting
200 enrolled
Registry of Older Patients With Cancer
Recruiting
3,000 enrolled
CarChem
Active not recruiting
169 enrolled
CHIS
Not yet recruiting
1,000 enrolled
Comparison of ATLG and ATG for Immune Reconstitution After Allo-HSCT for Hematologic Malignancy
Recruiting
24 enrolled
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
Recruiting
420 enrolled
Early Ageing During Therapy in AYA Cancer Patients
Recruiting
120 enrolled
Tempus Priority Study: A Pan-tumor Observational Study
Active not recruiting
1,000 enrolled
REDEFINE
Recruiting
130 enrolled
LeukemiaCort
Recruiting
40 enrolled
Blood Samples to Identify Biomarkers of Busulfan
Terminated
139 enrolled
MOHCCN-O
Recruiting
500 enrolled
Circulating microRNAs as Disease Markers in Pediatric Cancers
Completed
20 enrolled
Observational Study Relapsed or Refractory Chronic Lymphocytic Leukemia Venetoclax-based Regimens Outside Clinical Trials in Italy
Recruiting
321 enrolled
Understanding What Matters Most to Patients: Establishing the Validity of a Best-Worst Scaling Survey
Completed
51 enrolled 8 charts
BELUGA
Recruiting
25,000 enrolled
iPSC Neurons From Adult Survivors of Childhood Cancer Who Have Persistent Vincristine-Induced Neuropathy
Completed
137 enrolled
Post-authorization Safety Study of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Treated With Mogamulizumab
Recruiting
150 enrolled
Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
Recruiting
20,000 enrolled
HemaTMA
Active not recruiting
5,000 enrolled
Total Body Irradiation Treatments for Patients Treated at European Institute of Oncology
Recruiting
50 enrolled
SKETCh
Unknown
650 enrolled
ADLs at the End of Acute Treatment for Childhood Leukemia and Non-Hodgkin Lymphoma
Unknown
20 enrolled